N/A
Completed N=276
Music Based Caregiving in Patients With Pain and Dementia
Postoperative Pain · Dementia · Music · Activity, Motor
Source: ClinicalTrials.gov NCT04229446 ↗
Enrolled (actual)
276
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcomePrimary: Pain Occurence — 4.6; 4.6 units on Mobid-2 pain scale ( 0-10)
Summary
The main objective of this study is to evaluate the pain-relieving effect of a well-characterized non-pharmacological treatment program, music-based caregiving (MBC), to patients in nursing homes with dementia and pain. Patients with dementia disease will be recruited from nursing homes in Trondheim and Oslo, and each ward at the nursing homes will be cluster randomized into intervention - or control wards. Then the health care personnel in the intervention wards will receive education in MBC and perform the intervention during eight weeks. The hypothesis is that this non-pharmacological intervention will reduce pain intensity and improve general activity, as well as reduce other symptoms in nursing home patients with dementia and pain compared to baseline.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Occurence |
4.6; 4.6 | — |
| SECONDARY The Total Daily Physical Activity |
— | — |
| SECONDARY Stage of Dementia Disease |
— | — |
| SECONDARY Neuropsychiatric Symptoms |
— | — |
| SECONDARY Depression |
— | — |
| SECONDARY Level of Quality of Life: QUALID-scale |
— | — |
| SECONDARY Aids of Daily Living |
— | — |
Eligibility Criteria
Inclusion Criteria
- All patients living in one of the included nursing homes in Oslo or Trondheim will be included in the first descriptive phase
- Patients will be included in the intervention part if they report moderate pain or more (≥3 on MOBID) and mild dementia or more (≥1 on CDR).
Exclusion Criteria
- They will not be included if they have lived in the nursing home less than four weeks, have short (less than eight weeks) expected lifetime (judged by the nurses),or if they do not understand the Norwegian language.
Data sourced from ClinicalTrials.gov (NCT04229446). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.